- News
All the latest updates on building safety reformRegulations latest
- Focus
- Comment
- Programmes
- CPD
- Building the Future
- Jobs
- Data
- Subscribe
- Events
2024 events calendar
Explore nowBuilding Awards
Keep up to date
- Building Boardroom
A surge in optimism is wonderful to see, but material price inflation could put a brake on construction’s rebound
There is a buzz in the air this week as easing covid restrictions allowed people to shop for non-essential items, meet up for outdoor drinking and, perhaps most pressing of all, finally get a haircut. And the upbeat mood has been matched in the world of construction: our own survey shows industry optimism about future work prospects has jumped by 90% compared with the dark days at the end of last year. Official figures suggest there are good reasons to be cheerful, growth in new commercial work has helped construction output reach its highest level in six months. February’s GDP figures show output across the whole industry grew 1.6%, one of the strongest parts of the economy, which recorded a more modest 0.4% increase.
Clearly, we are not back to where we were before the pandemic, but the economy is beginning to reopen thanks to a successful UK vaccine rollout, which has met its target of offering all the over 50s a jab by the middle of this month. That is quite an achievement.
It is particularly heartening to see confidence returning to the commercial sector. The latest IHS Markit/CIPS data also revealed the strong rebound many had been predicting – with its highest score from purchasing managers since September 2014 – as work resumes on stalled office jobs and the hospitality and leisure sectors reopen.
…
Existing subscriber? LOGIN
Stay at the forefront of thought leadership with news and analysis from award-winning journalists. Enjoy company features, CEO interviews, architectural reviews, technical project know-how and the latest innovations.
Get your free guest access SIGN UP TODAY
Subscribe to Building today and you will benefit from:
View our subscription options and join our community